Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Determining the Effect of the HNMT, STK39, and NMD3 Polymorphisms on the Incidence of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Multiple System Atrophy in Chinese Populations.

Chen Y, Cao B, Ou R, Wei Q, Chen X, Zhao B, Wu Y, Song W, Shang HF.

J Mol Neurosci. 2018 Apr;64(4):574-580. doi: 10.1007/s12031-018-1048-8. Epub 2018 Mar 21.

PMID:
29564728
2.

Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome.

Jiménez-Jiménez FJ, García-Martín E, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, Adeva-Bartolomé T, Cubo E, Navacerrada F, Rojo-Sebastián A, Rubio L, Ortega-Cubero S, Pastor P, Calleja M, Plaza-Nieto JF, Pilo-de-la-Fuente B, Arroyo-Solera M, García-Albea E, Agúndez JA.

J Neural Transm (Vienna). 2017 Mar;124(3):285-291. doi: 10.1007/s00702-016-1645-z. Epub 2016 Nov 11.

PMID:
27837280
3.

Thr105Ile (rs11558538) polymorphism in the histamine N-methyltransferase (HNMT) gene and risk for Parkinson disease: A PRISMA-compliant systematic review and meta-analysis.

Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JA.

Medicine (Baltimore). 2016 Jul;95(27):e4147. doi: 10.1097/MD.0000000000004147. Review.

4.

Association of histamine N-methyltransferase Thr105Ile polymorphism with Parkinson's disease and schizophrenia in Han Chinese: a case-control study.

Yang X, Liu C, Zhang J, Han H, Wang X, Liu Z, Xu Y.

PLoS One. 2015 Mar 13;10(3):e0119692. doi: 10.1371/journal.pone.0119692. eCollection 2015.

5.

Genomic and pharmacogenomic biomarkers of Parkinson's disease.

Alonso-Navarro H, Jimenez-Jimenez FJ, Garcia-Martin E, Agundez JA.

Curr Drug Metab. 2014 Feb;15(2):129-81. Review.

PMID:
24694231
6.

Histamine N-methyltransferase Thr105Ile polymorphism is associated with Parkinson's disease.

Palada V, Terzić J, Mazzulli J, Bwala G, Hagenah J, Peterlin B, Hung AY, Klein C, Krainc D.

Neurobiol Aging. 2012 Apr;33(4):836.e1-3. doi: 10.1016/j.neurobiolaging.2011.06.015. Epub 2011 Jul 27.

PMID:
21794955
7.

No association between histamine N-methyltransferase functional polymorphism Thr105Ile and Alzheimer's disease.

Marasović-Šušnjara I, Palada V, Marinović-Terzić I, Mimica N, Marin J, Muck-Seler D, Mustapić M, Presečki P, Pivac N, Folnegović-Šmalc V, Marinović-Ćurin J, Terzić J.

Neurosci Lett. 2011 Feb 4;489(2):119-21. doi: 10.1016/j.neulet.2010.11.078. Epub 2010 Dec 5.

PMID:
21138759
8.

Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor.

Keeling BH, Vilariño-Güell C, Soto-Ortolaza AI, Ross OA, Uitti RJ, Rajput A, Wszolek ZK, Farrer MJ.

Parkinsonism Relat Disord. 2010 Feb;16(2):112-4. doi: 10.1016/j.parkreldis.2009.08.011. Epub 2009 Sep 20.

9.

The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor.

Ledesma MC, García-Martín E, Alonso-Navarro H, Martínez C, Jiménez-Jiménez FJ, Benito-León J, Puertas I, Rubio L, López-Alburquerque T, Agúndez JA.

Neuromolecular Med. 2008;10(4):356-61. doi: 10.1007/s12017-008-8040-3. Epub 2008 Jun 10.

PMID:
18543121
10.

Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease.

Agúndez JA, Luengo A, Herráez O, Martínez C, Alonso-Navarro H, Jiménez-Jiménez FJ, García-Martín E.

Neuromolecular Med. 2008;10(1):10-6. Epub 2007 Nov 6.

PMID:
17985251

Supplemental Content

Loading ...
Support Center